What Is a Certificate of Analysis for Peptides?
A certificate of analysis for peptides is a batch-specific lab report on identity and purity. Here is what it contains and why the batch number matters.
Anthony Russo, DO, MS is a Doctor of Osteopathic Medicine with a Master of Science in clinical research whose background spans regenerative medicine and peptide therapeutics.
A certificate of analysis for peptides is a lab report tied to one production batch, stating what testing found about that batch’s identity and purity. It is issued after a specific synthesis run has been tested, not written in advance as a general description of the product line. When a listing shows a certificate of analysis for peptides, the useful question is whether that document corresponds to the vial being sold, or whether it is a stock image reused across every restock regardless of what actually shipped.
What the Document Reports
A certificate of analysis is typically organized around a small set of findings rather than a single number. The common elements are:
- Identity confirmation — evidence that the tested material matches the peptide named on the label, usually established through mass spectrometry.
- Purity result — the share of the sample attributable to the target peptide, usually measured by high-performance liquid chromatography (HPLC).
- Batch or lot number — the specific production run the report describes, distinct from the product listing as a whole.
- Date of testing — when the analysis ran, which is relevant because peptide material can change over time in storage.
- Physical description — a short note on the appearance of the lyophilized powder and how it dissolves on reconstitution.
A listing that shows only a purity percentage with no batch number and no test date is presenting a claim, not a certificate of analysis for peptides in the sense the term is meant to convey. The document’s value comes from being specific to a lot, not from the number printed on it.
Identity and Purity Are Separate Questions
HPLC and mass spectrometry test for different things, and a complete report includes both rather than one standing in for the other.
HPLC separates the components of a sample as they move through a column and measures the relative area under each resulting peak. The percentage reported as purity is the share of total peak area attributed to the target compound. A dominant peak with small, clearly separated shoulder peaks points to a sample with little in the way of leftover synthesis byproducts.
Mass spectrometry measures the mass-to-charge ratio of ionized molecules, which confirms that the main component actually has the molecular weight expected for the named peptide. That is a different check than purity. A sample can post a high purity percentage on HPLC and still be the wrong compound if identity was never verified separately, which is why a purity number alone is a partial answer.
| Report section | What it confirms | Typical method |
|---|---|---|
| Identity | Molecular weight matches the labeled peptide | Mass spectrometry |
| Purity | Share of sample matching the target compound | HPLC |
| Batch/lot number | Which production run the results describe | Internal lab tracking |
| Test date | When the analysis was run | Lab records |
| Appearance | Description of the lyophilized powder | Visual inspection |
Why the Batch Number Carries the Most Weight
A certificate of analysis is only as useful as the link between the document and the vial in front of a reader. Synthesis runs vary from batch to batch, since reagent lots, reaction conditions, and purification steps are never perfectly identical across production cycles. A supplier that tests each batch separately and prints a matching lot number on both the vial and the certificate is documenting the specific item sold. A listing that reuses one certificate of analysis for peptides across several restocks, with no lot number tying the document to a particular production run, gives a reader no way to check that the two correspond.
This is also where purity numbers on a certificate can be misread. A figure like “98.5% purity” describes peak area under stated HPLC conditions for one tested batch, not a permanent property of the product line. Different columns, mobile phases, or detection settings can produce slightly different readings for chemically similar material, which is one reason thorough reports note the testing conditions rather than the percentage in isolation.
What the Report Does Not Cover
A certificate of analysis speaks to the composition of the material as tested at the time of testing. It does not, by default, address sterility, endotoxin levels, or how the vial was handled after it left the lab, unless those items are listed separately as their own results. Some suppliers add microbial or endotoxin testing on top of identity and purity; many do not, and that gap is worth noticing rather than assuming away. The report also says nothing about conditions during shipping or storage after manufacture, since the analysis happens before the vial goes out the door. Treating a certificate of analysis for peptides as covering everything about a vial’s condition on arrival overstates what the document actually verifies.
Comparing Documentation Across Listings
Because testing practices differ widely across sellers, the mere presence of a certificate is not itself a sign of quality. What separates useful documentation from decorative documentation is whether the report is batch-specific, dated, produced by a named outside lab rather than asserted in-house, and covers both identity and purity rather than purity alone. Catalogue pages that pair a compound like tirzepatide or ghk-cu with dated, lot-matched testing records, the way the HEEZ Research listing for BPC-157 does, give a reader more to evaluate than a bare percentage on its own. Reading past the headline number to check for a lot number and a named testing lab is the more reliable habit when comparing one listing’s documentation against another’s.
Summary
A certificate of analysis for peptides is a batch-specific lab report, not a permanent spec sheet, and its usefulness depends on whether it ties a stated identity and purity result to a lot number matching the vial in hand. HPLC and mass spectrometry answer different questions — proportion of target compound versus confirmed molecular identity — and a thorough report includes both. The document does not, on its own, address sterility or post-manufacture handling unless those results appear as separate line items. Checking for a lot number, a test date, and a named outside lab is a more reliable way to read a certificate of analysis than looking at the purity percentage alone.